FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1163322001: Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4595929012 Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4595930019 Ranolazine 750 mg prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug) Is a Product containing only ranolazine in oral dose form (medicinal product form) true Inferred relationship Some
Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form Prolonged-release oral tablet true Inferred relationship Some
Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Ranolazine (substance) true Inferred relationship Some 1
Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Ranolazine (substance) true Inferred relationship Some 1
Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 1
Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 1
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start